Kaye Jack sold $225K of QURE
Kaye Jack sold 5,295 shares of uniQure N.V. (QURE) at $42.57 ($0.23M total) on 2026-06-17 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest concrete fact is the director’s open-market sale of 5,295 shares at $42.57 on 2026-06-17, with holdings after the trade and confirmation of a pre-arranged 10b5-1 plan.
Market read
Traders may note insider selling, but the 10b5-1 structure makes it more of a sentiment datapoint than a fundamental catalyst.
What to watch
The filing doesn’t disclose new company performance, guidance, or risk changes—so traders should avoid over-weighting it versus upcoming catalysts (earnings/clinical/regulatory).
Background
The article is an SEC Form 4 insider transaction disclosure for uniQure N.V. (QURE).
Ticker impact
uniQure director Kaye Jack sold 5,295 shares in an open-market transaction on 2026-06-17 for about $225.4K.
Low likelihood of a sustained price move; any reaction is likely muted and short-lived.
The filing is a Form 4 insider transaction with a stated 10b5-1 plan, which typically reduces signaling value versus discretionary sales.
Market effects
Minimal; single-company insider sale without clinical/regulatory updates provides no sector read-through.
None indicated; event is company-specific and small relative to market cap.
None indicated; no cross-border deal/regulatory action described.
Counterpoint
Because the sale was executed under a pre-arranged 10b5-1 plan, it may reflect liquidity planning rather than bearish expectations.
Key entities
- issueruniQure N.V.
Company whose director insider sale is disclosed via SEC Form 4.
- insiderKaye Jack
Director who sold shares under an open-market transaction tied to a 10b5-1 plan.
